#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary aspergillosis Glioblastoma Pseudomyxoma peritonei Penile cancer Pleural mesothelioma malignant Adrenoleukodystrophy Dedifferentiated liposarcoma Acromegaly Ventricular fibrillation Kearns-Sayre syndrome Myelodysplastic syndrome with excess blasts Lennox-Gastaut syndrome Amyloidosis Mantle cell lymphoma stage II Chronic myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Diagnostics Mucopolysaccharidosis II – Treatment Osteosarcoma – Basic Information Friedreich’s ataxia – Basic Information Myelodysplastic syndrome with excess blasts – Basic Information Short-bowel syndrome – Basic Information Loeys-Dietz syndrome – Trials in Disease Acquired haemophilia – Treatment VEXAS syndrome – Treatment Tuberous sclerosis complex More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VINBLASTINE Hu5F9‐G4 Disitamab Vedotin [14C] DC-806 Anv600 HUPERZINE A Cisatracurium Besilate ALXN2420 Miglustat SEPOFARSEN TEV-53408 Melphalan Hydrochloride Pyridoxine Hydrochloride Bp Choriogonadotropin Alfa Mbf-015 Art6043 Somatostatin Cd7-Cart01 Dextrose Bp Fezolinetant More therapies…

    Learn about Your Condition

    Colitis Frontotemporal dementia Prader-Willi syndrome Adrenocortical carcinoma Anogenital dysplasia Craniocerebral injury Ocular hypertension Drug use disorder Clinically isolated syndrome Meniere's disease Stem cell transplant Hypocalcaemia Neoplasm malignant High-grade B-cell lymphoma Ulcerative keratitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • TEDUGLUTIDE
    • Apixaban
    Belgium

  • Study on Using Ultrasound with Perflubutane and Laxative for Detecting Crohn’s Disease in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Perflubutane
    • Macrogol 3350
    • Sodium Hydrogen Carbonate
    Norway

  • Study on Pain Relief Using Lidocaine and Sodium Chloride in Patients with Chronic Inflammatory Bowel Disease and Abdominal Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    Belgium

  • Study of Simvastatin with Nivolumab and Oxaliplatin for Patients with Advanced Stomach or Esophageal Cancer with ARID1A Mutation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Human epidermal growth factor receptor negative
    Investigated Drugs:
    • Simvastatin
    • Capecitabine
    • Fluorouracil
    Italy

  • Study on the Safety of Using Autologous Stromal Vascular Fraction Cells and Micrograft for Treating Hard-to-Heal Ano-Perineal Fistulas in Crohn’s Disease Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    France

  • Study on the Effectiveness and Safety of Colesevelam Hydrochloride for Patients with Idiopathic Bile Acid Diarrhea (BAD)

    Recruiting

    2 1
    Investigated Drugs:
    • COLESEVELAM HYDROCHLORIDE
    Belgium Denmark Italy Romania Spain
Previous Page
1 … 10 11 12 13 14 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!